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ABSTRACT
Background. In the Netherlands, differentiated thyroid
cancer (DTC) is treated surgically in three different hos-
pital types, including university, teaching, and non-
teaching peripheral hospitals. This study evaluates post-
operative complications and referral patterns in patients
with DTC in the northern region of the Netherlands to gain
an understanding on how to improve management
implementation.
Methods. Data from 567 patients diagnosed between 1989
and 2009 were obtained from the Netherlands Cancer
Registry and were supplemented with information from
hospital digital information systems and patient records
from 15 hospitals: 1 university, 3 teaching, and 11
peripheral hospitals. Surgically treated patients with a
histologically proven DTC derived from the original
pathology reports were included.
Results. Surgical treatment could be performed in a single
procedure in 234 patients (41.3%), but several surgeries
were needed in the remaining 333 patients (58.7%).
Recurrent laryngeal nerve (RLN) palsy occurred after all
types of thyroid surgical procedures, but mostly after initial
(hemi)thyroidectomy and reoperations. RLN was tempo-
rary in 3.2% of the nerves at risk and persistent in 1.8%.
Temporary hypocalcemia developed in 13.7% of patients,
and persistent hypocalcemia occurred in 4.8%. Patients
were mainly referred to the university hospital from a non-
teaching (40.7%, 48/118) or teaching hospital (11.1%,
16/144); however, 80% of patients were not referred.
Conclusions. The complication rate and number of mul-
tiple surgeries support the efforts in optimizing clinical
management in thyroid cancer. Careful considerations prior
to initial surgical treatment by early discussion in tele-
medicine-based regional tumor boards could possibly
prevent reoperations and potentially diminish
complications.
The number of newly diagnosed patients with differen-
tiated thyroid cancer (DTC) in the Netherlands has steadily
increased from 250 in 1989 to 487 in 2009, and up to 607
in 2016.1 The rise in thyroid cancer incidence is likely due
to the detection of early-stage tumors, and caused by
overdiagnosis.2–4 Generally, DTC is a well-treatable dis-
ease with a favorable prognosis and a 10-year survival rate
of 80–95%.5,6 Surgery is the basis of treatment with
curative intent for patients with DTC, but has potentially
harmful consequences. The most common complications
after surgical treatment of thyroid cancer are
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hypoparathyroidism and recurrent laryngeal nerve (RLN)
paralysis, with reported risks of 1–38% and 0.9–8.0%,7–12
respectively, both leading to lifelong morbidity and
diminished quality of life (QoL).13 With the increasing
incidence of low-risk DTC in the last decades, the extent of
surgery has been reduced, thereby preventing surgical
complications, while cancer-related survival remained
equal.14
Morbidity in DTC patients can be reduced by accurate
selection of patients and optimizing treatment strategies by
standardizing treatment protocols and referral patterns.
Traditionally, patients with DTC in the Netherlands were
referred for surgical treatment based on expert opinion,
surgeon experience, extensiveness of the disease, and the
extent of primary or secondary treatment. The National
Thyroid Cancer treatment guidelines update was published
in 2007 to ensure that treatment decisions are made in a
consistent manner across all hospitals for every patient
with a suspected thyroid nodule or DTC.15 Based on these
guidelines, treatment protocols were gradually standard-
ized throughout the country, aiming to improve adequate
initial treatment strategies with less reoperations and
thereby decreasing morbidity through better QoL in
patients with DTC.
Guidelines for the treatment of thyroid cancer are lar-
gely established on expert opinion and/or are consensus-
based. Even today, most data are retrieved from retro-
spective studies, as the possibility of prospective studies
remains limited in these patients. Validation studies are
important to assess patient outcomes after implementation
of current guidelines and to understand the impact of
modifications in the guidelines for treatment of DTC;
therefore, these large, population-based studies are still
indispensable. They can be used as validation and for
future reference in comparing outcomes after prospective
guideline modifications.
In this study, we evaluated surgical complications in
DTC patients, in particular RLN palsy and hypocalcemia.
We correlated these to the extent and number of surgical
procedures for DTC with respect to hospital level and
referral patterns in the northern part of the Netherlands
between 1989 and 2009, i.e. the period before consensus
management and full implementation of the Dutch Thyroid
Guidelines.
METHODS
Patient and Data Collection
The northern region of the Netherlands, a catchment
area for 2.2 million patients, harbors 1 university medical
center, 3 teaching hospitals, and 12 non-teaching,
peripheral hospitals.16 From 1989 on, data from all DTC
patients treated in the Netherlands have been registered by
the Netherlands Cancer Registry (NCR). Population-based
data retrieved from the NCR are based on notification of all
newly diagnosed malignancies in the Netherlands by the
Pathological Anatomical National Automated Archive
(PALGA), supplemented by information from the national
registry of cancer-related hospital discharges. Complete-
ness is estimated at[ 95%.17 In this retrospective study,
we identified 791 DTC patients in the NCR who were
treated in the northern region between 1989 and 2009, prior
to consensus management and full implementation of the
Dutch Thyroid Guidelines.
Fifteen of the 16 hospitals agreed to participate and
approved additional data collection for this study. One
small non-teaching peripheral hospital declined our request
to collect additional patient information, leaving 11
peripheral hospitals with a total of 780 patients. Patients
were included when the original pathology reports of thy-
roid surgical procedures could be retrieved. For 192
patients, pathology reports were not available. Patients who
did not receive any surgical treatment, e.g. patients with
tumors found at autopsy (n = 18) and patients who died
before treatment could be initiated (n = 3) were excluded
for all calculations, resulting in a total of 567 included
patients. Demographics of the included and excluded
patients are provided in electronic supplementary Table S1.
Data from the NCR of all included patients were uni-
formly supplemented with data from digital hospital
information systems and patient records. All well-differ-
entiated thyroid cancer variants (papillary, follicular, and
Hürthle cell carcinomas) were included. Histology was
registered according to the International Classification of
Diseases for Oncology, Third Edition (ICD-O-3). During
the study period, we used the concurrent version of the
TNM classification system, including the 3rd edition from
1989 to 1992, the 4th edition between 1993 and 1997, the
5th edition between 1998 and 2002, and the 6th edition
from 2003 to 2009. Because of the retrospective design of
this population-based study and the anonymous data pro-
cessing, the Institutional Review Board waived further
approval according to Dutch law at the time of inclusion.
All data were fully anonymized before performing
analyses.
Definitions
Recurrent or persistent disease is usually an indication
for follow-up surgery. Recurrence was defined as
detectable Tg-on (i.e. Tg during substitution therapy) and/
or tumor detectable, either on diagnostic imaging or at
physical examination, commonly with cytological or
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histological confirmation of tumor during follow-up after
an initial curation.18
Persistent disease was defined as a continuous existence
of microscopic disease (i.e. cytopathologically/histopatho-
logically and/or detectable Tg-on) or
detectable macroscopic disease (i.e. on physical examina-
tion, imaging, or last surgery), as previously described.18,19
Transient or persistent RLN paralysis was defined as
paralysis of one or both RLNs for a period of\ 1 year
or[ 1 year, respectively. Nerve dysfunction was diag-
nosed either peroperatively, clinically, or through
laryngoscopy. Intentionally sacrificed nerves due to gross
tumor invasion or encasement, visible during surgery, were
not recorded as a complication. Transient and persistent
hypocalcemia was defined as low serum calcium, for which
suppletion therapy with calcium and/or active vitamin D
was necessary for\ 1 year or[ 1 year, respectively.
TNM stage was based on the original pathology report after
initial surgery and, if applicable, on the results of the first
post-ablation radioactive iodine (131I) scan.
Subdivision of Hospitals
To assess treatment strategies and referral patterns, the
participating hospitals were subdivided into three cate-
gories as described in the Dutch 2007 guidelines: Level IA:
university hospital; Level IB: teaching hospital; and Level
II: non-teaching, peripheral hospital.15 These levels were
implemented after the inclusion period of this study.
Subdivision of Surgical Procedures
In order to classify the surgically related complications,
operations were categorized according to the anatomically
defined surgical procedures described by van Dijk et al.20
and Robbins et al.21 (Fig. 2).
1. Surgery in the central compartment (i.e. thyroid region
and nodes in levels VI and VII):
• HT ± CCD/LND: initial hemithyroidectomy (HT;
with or without unilateral central compartment
lymph node [LN] dissection [CCD]; or HT with
additional exploration/LN dissection in the lateral
neck [LND]).
• TT ± CCD: total thyroidectomy (TT; with or
without central compartment LN dissection
[CCD]).
• TT ± CCD ? LND: total thyroidectomy with
additional lateral neck dissection (with or without
central compartment LN dissection).
• MISC: miscellaneous (surgery not otherwise
specified; mediastinoscopy with node removal;
metastasectomy; neck exploration).
• REOP CCD UNIL/BIL: reoperation in the central
compartment, unilateral/bilateral.
2. Surgery only in the lateral compartment (i.e. LN dis-
section at levels II–V):
• UNIL LND: unilateral lateral neck dissection.
• BIL LND: bilateral lateral neck dissection.
• REOP LND: reoperation outside the central com-
partment (lateral neck dissection).
Surgical-Related Complications
Surgical complications were scored per surgical proce-
dure. Some patients had multiple complications after one
surgical procedure. To determine RLN paralysis, it is
important to know whether patients were operated unilat-
erally or bilaterally, since one or both laryngeal nerves
could be at risk, respectively. Therefore, RLN paralysis
was scored per nerve at risk. Thus, bilateral surgical pro-
cedures (type TT ± CCD, TT ± CCD ? LND, and REOP
BIL) are multiplied by a factor of two (Table 4).
Statistical Methods
Normally distributed data are expressed as mean with
standard deviation (SD). Numbers and percentages are
reported throughout the paper. Chi square or Fisher exact
tests were used when applicable. A two-sided
p value\ 0.05 was considered to be statistically signifi-
cant. Statistical analyses were performed using IBM SPSS
for Windows version 23 (IBM Corporation, Armonk, NY,
USA).
RESULTS
Patient and Tumor Characteristics
Patient and tumor characteristics of the 567 included
patients, at the time of diagnosis, are reported in Table 1.
Most patients had a papillary thyroid carcinoma (n = 419,
73.9%) and were diagnosed at a mean age of 49.2 years
(SD 17.7). The majority had a T1 or T2 tumor (n = 352,
62.1%), whereas 195 patients (34.4%) presented with a T3
or T4 locally advanced thyroid carcinoma; 159 (28.0%)
patients had LN metastases at presentation and 26 (4.6%)
presented with distant metastases. DTC was an incidental
finding during non-thyroid-related surgery in the head and
neck region in 30 patients (5.3%); In most of these cases, a
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median or lateral neck cyst or reactive LN was suspected.
If these 30 patients underwent subsequent hemithyroidec-
tomy or total thyroidectomy with or without additional
central compartment LN dissection, these surgical inter-
ventions were scored as the ‘initial thyroid cancer-related
operation’. The included 567 patients underwent 948 thy-
roid-related surgical procedures (Table 1). In total, 234
patients (41.3%) had one operation, whereas the remaining
333 patients (58.7%) underwent multiple surgeries (Fig. 1).
Of these 333 patients, 296 (52.2%) underwent two opera-
tions, 28 (4.9%) underwent three operations, 7 (1.2%)
underwent four operations, and 2 (0.4%) patients under-
went five operations. Patients with follicular thyroid
carcinoma more often had multiple surgeries compared
with patients with papillary thyroid carcinoma (p\ 0.01);
76.4% of patients with follicular thyroid carcinoma
received multiple operations, versus 52.5% of patients with
papillary carcinoma. Patients with locally advanced T3 or
T4 tumors were significantly more often treated with
multiple surgical procedures than patients with smaller
tumors (p = 0.02) (Table 1); they were more frequently
operated in the university hospital (41.1%) compared with
teaching (32.6%) and peripheral hospitals (29.6%),
although this was not significantly different (p = 0.06).
Referral Patterns
Referral patterns of DTC patients in the northern part of
the Netherlands are shown in Fig. 1. Fifty-eight of 567
patients (10.2%) were directly referred, after initial diag-
nosis, to the university hospital (n = 56, 96.6%) or teaching
hospital (n = 2, 3.4%) for surgical treatment. In these 58
patients, locally advanced tumors (T3/T4) were present in
28 patients (47.5%), LN metastases were present in 35
patients (55.9%), and distant metastases were present in 9
patients (15.3%).
Of the 234 patients with one surgical procedure, 103
(44.0%, 103/234) were operated in the university hospital,
87 (37.0%, 87/234) were operated in the teaching hospitals,
and 44 (18.8%, 44/234) were operated in the peripheral
hospitals. Of the 174 patients who had their initial opera-
tion in the university hospital, 40.8% (71/174) had a
subsequent resection, compared with 62.3% (144/231) and
72.8% (118/162) in the teaching and peripheral hospitals,
respectively (p\ 0.01).
If a second operation was needed, 80% of patients were
treated in the hospital of the primary surgery (267/333,
80.2%). If referral took place, patients were mostly referred
from a peripheral (40.7%, 48/118) or teaching hospital
(11.1%, 16/144) to the university hospital. There was no
difference in referral rate between patients with locally
advanced tumors (T3/T4; 40.8%) and patients with small
tumors (T1/T2; 59.2%) [p = 0.24]. There was no difference
TABLE 1 Patient and tumor
characteristics at diagnosis, and
related numbers of surgery
Patients Surgeries One surgery Multiple surgeries
Total 567 (100) 948 (100) 234 (100) 333 (100)
Male 150 (26.5) 260 (27.4) 60 (25.6) 90 (27.0)
Female 417 (73.5) 688 (72.6) 174 (74.4) 243 (73.0)
Age at diagnosis, years (mean ± SD) 49.2 ± 17.7 NA 51.6 ± 19.2 47.6 ± 16.4
Papillary carcinoma 419 (73.9) 673 (71.0) 199 (85.1) 220 (66.1)
Follicular carcinoma (including Hürthle) 148 (26.1) 275 (29.0) 35 (14.9) 113 (33.9)a
TX 20 (3.5) 37 (3.9) 5 (2.1) 15 (4.5)
T1 139 (24.5) 209 (22.0) 75 (32.1) 64 (19.2)
T2 213 (37.6) 361 (38.1) 75 (32.1) 138 (41.5)
T3 112 (19.8) 192 (20.3) 44 (18.8) 68 (20.4)
T4 83 (14.6) 149 (15.7) 35 (15.0) 48 (14.4)
NX 319 (56.3) 544 (57.4) 112 (47.9) 207 (62.2)
N0 89 (15.7) 140 (14.8) 40 (17.1) 49 (14.7)
N1 159 (28.0) 264 (27.8) 82 (35.0) 77 (23.1)
MX 165 (29.1) 278 (29.3) 70 (29.9) 95 (28.5)
M0 376 (66.3) 625 (65.9) 154 (65.8) 222 (66.7)
M1 26 (4.6) 45 (4.8) 10 (4.3) 16 (4.8)
Data are expressed as n (%) unless otherwise specified
T tumor, N nodes, M metastases, X unknown, NA not applicable, SD standard deviation
aPatients with follicular thyroid carcinoma more often had multiple surgeries compared with patients with
papillary thyroid carcinoma (p\ 0.01)
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in complication rate in referred (46.9%, 23/49) versus
unreferred (31.9%, 22/69) patients treated initially in a
peripheral hospital (p = 0.23).
Two patients were referred from the university hospital
to a teaching hospital—one after initial diagnosis and one
for follow-up surgery. No patients were referred from the
university and teaching hospitals to peripheral hospitals. Of
the 134 patients who had their subsequent surgery in the
university hospital, 64 (47.8%) were referred, of whom
75.0% (48/64) were referred from peripheral hospitals.
Surgical Procedures Regarding Hospital Level
As shown in Tables 2 and 3, all surgical procedures
were subdivided according to their localization in the neck,
i.e. at the central (Table 2) or lateral compartment
(Table 3, Fig. 2), and hospital level. In the teaching and
peripheral hospitals, hemithyroidectomy as an initial pro-
cedure was most often performed in 37.6% (137/364) and
52.4. % (122/233) of patients, respectively. By compar-





























































FIG. 1 Referral patterns in the northern part of the Netherlands
between 1989 and 2009. Of the total 567 patients, 58 were
immediately referred, after initial diagnosis, to another hospital for
surgical treatment. *A total of 234 (103 ? 87 ? 44) patients (41.3%)
received one operation. **A total of 333 (71 ? 144 ? 118) patients
(58.7%) received multiple surgical treatments
TABLE 2 Total numbers of
surgery within the central
compartment according to
hospital level
Type of surgery University hospital Teaching hospital Peripheral hospital Total
HT ± CCD/LND 47 (15.4) 137 (44.8) 122 (39.8) 306 (100)
TT ± CCD 79 (50.3) 56 (35.7) 22 (14.0) 157 (100)
TT ± CCD ? LND 57 (69.5) 24 (29.3) 1 (1.2) 82 (100)
MISC 40 (45.5) 29 (33.0) 19 (21.5) 88 (100)
REOP CCD UNIL/BIL 83 (30.7) 118 (43.7) 69 (25.6) 270 (100)
Total 306 (33.9) 364 (40.3) 233 (25.8) 903 (100)
Data are expressed as n (%)
Operations including both the central and lateral compartments are listed in Tables 2 and 3
HT ± CCD/LND hemithyroidectomy (with or without central or lateral compartment LN dissection),
TT ± CCD total thyroidectomy (with or without central compartment LN dissection), TT ± CCD ? LND
total thyroidectomy with lateral compartment LN dissection (with or without central compartment LN
dissection), MISC other (surgery not otherwise specified, mediastinoscopy, metastasectomy), REOP CCD
UNIL/BIL: reoperation in the central compartment, unilateral or bilateral, LN lymph node
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without lateral compartment dissection) was more often
performed as initial surgery in 44.4% (136/306) of patients.
Lateral neck dissections, whether unilateral or bilateral,
were commonly performed in the university and teaching
hospitals (Table 3). A unilateral lateral neck dissection was
carried out in 29 patients (56.9%) in the university hospital,
18 patients (35.3%) in the teaching hospitals, and 4 patients
(7.8%) in the peripheral hospitals. Bilateral lateral neck
dissections and reoperations of nodal metastases in the
lateral neck (levels II–VI) were mostly (70.0% and 89.3%,
respectively) performed in the university hospital, while
30.0% and 10.7%, respectively, were performed in teach-
ing hospitals.
Thyroid Surgery-Specific Complications
The two most common thyroid surgery-specific com-
plications—RLN palsy and hypocalcemia—are outlined in
Tables 4 and 5. Table 4 shows the percentage of RLN
palsy according to the type of surgery in the central com-
partment. In 3.2% of the nerves at risk, a temporary RLN
palsy occurred and RLN palsy was persistent in 1.8%. RLN
palsy occurred after all types of surgery, i.e. in 19 patients
(6.2%) after initial hemithyroidectomy, 16 patients (5.1%)
after total thyroidectomy, and 13 patients (4.5%) after
reoperation. Nine patients (16.1%, 9/56) operated in the
university hospital developed RLN palsy, versus 25
(44.6%, 25/56) patients operated in the teaching hospitals
and 22 (39.3%, 22/56) in the peripheral hospitals (p = 0.9).
In Table 5, the percentages of postoperative temporary
and persistent hypocalcemia are shown according to the
type of surgery in the central compartment. In some
patients, the exact duration of recurrent nerve palsy (n = 4/
1142 total nerves at risk) or hypocalcemia (n = 30/903
surgeries with postoperative hypocalcemia) was unknown.
These patients were categorized as transient for the anal-
yses. In total, 124 patients (13.7%) developed temporary
hypocalcemia and 43 patients (4.8%) had persistent
hypocalcemia. Hypocalcemia occurred most frequently
after initial total thyroidectomy with (n = 44, 53.7%) or
without (n = 43, 27.3%) a concomitant lateral neck dis-
section, and in 65 patients (24.1%) after reoperation. Nine
patients developed temporary hypocalcemia after an initial
hemithyroidectomy, of whom two patients even developed
permanent hypocalcemia.
Other thyroid surgery-related complications (electronic
supplementary Table S2) were Horner’s syndrome in two
patients, a partial facial nerve palsy in two patients, and an
accessory nerve palsy in four patients. One patient had a
vagal nerve palsy and two patients experienced a tempo-
rary hypoglossal nerve palsy. Chyle leakage was reported
in seven patients.
TABLE 3 Total numbers of
surgery limited to the lateral
compartment according to
hospital level
Type of LN dissection University hospital Teaching hospital Peripheral hospital Total
UNIL LND 29 (56.9) 18 (35.3) 4 (7.8) 51 (100)
BIL LND 7 (70.0) 3 (30.0) 0 (0.0) 10 (100)
REOP LND 25 (89.3) 3 (10.7) 0 (0.0) 28 (100)
Total 61 (68.5) 24 (27.0) 4 (4.5) 89 (100)
Data are expressed as n (%)
Operations including both the central and lateral compartments are listed in Tables 2 and Table 3
UNIL LND unilateral LN dissection, BIL LND bilateral LN dissection, REOP LND reoperation LN dis-
section outside the central compartment, LN lymph node
Level      I
Level    II
Level   III
Level    V
Level  VII
Level   IV
Level   VI
FIG. 2 The system of lymph node levels in the neck, as described by
Robbins et al.21 Level I: submental and submandibular group, lymph
nodes within the boundary of the subdigastric muscles and the hyoid
bone. Levels II/III/IV: Upper, middle, and lower jugular group, lymph
nodes located around the internal jugular vein, sternohyoid muscle
anteriorly, sternocleidomastoid muscle posteriorly, skull base
superiorly, and clavicle inferiorly. Level V: Posterior triangle
group, located between the sternocleidomastoid muscle and the
trapezius muscle, including suprasternal lymph nodes. Level VI:
Anterior compartment, located in the midline between the carotid
sheets, from the hyoid bone superiorly to the suprasternal notch
inferiorly. Level VII: Mediastinal lymph nodes. Image modified from
de Groot et al.20
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Other Complications
General postoperative complications, recorded up to
1 year after surgery, included postoperative bleeding in 33
patients, wound infection in 22 patients, and pneumonia in
9 patients (electronic supplementary Table S2).
DISCUSSION
This retrospective study gives an overview of thyroid
cancer-specific complications in DTC patients in regard to
the type and number of surgeries related to hospital level
and referral pattern in the northern part of the Netherlands
between 1989 and 2009. Our data show that all types of
thyroid cancer surgery were performed in all hospital
levels, which may lead to increased thyroid surgery-related
complications. Patients with follicular thyroid carcinoma
more often had multiple surgeries compared with patients
with papillary thyroid carcinoma. Higher T-stage tumors
require a more extensive and higher number of operative
treatments, which is more or less biological inherent. Our
data further show that patients treated in the university
hospital have less follow-up surgeries compared with the
other hospital levels. Since high complication rates were
seen after reoperation, we advocate early discussion in
regional tumor boards prior to initial treatment to prevent
follow-up surgeries and potentially prevent complications.
In this cohort, temporary RLN palsy occurred in
approximately 3% of the nerves at risk, and persistent RLN
palsy occurred in\ 2% (Table 4). These rates are in
accordance with the literature, with temporary and persis-
tent RLN palsy rates of between 2.0 and 8.0%, and 0.9 and
3.0%, respectively.11,22 High percentages of RLN palsy
were seen in the reoperation group, but even higher per-
centages were seen in the initial (hemi)thyroidectomy
group. This might be explained by the fact that
TABLE 4 Recurrent nerve
palsy according to type of
surgery and nerves at risk
Type of surgery Total number of nerves at risk Recurrent nerve palsy [n (%)]
Temporary Persistent Total
HT ± CCD/LND 306 12 (3.9) 7 (2.3) 19 (6.2)
TT ± CCD 314 10 (3.2) 6 (1.9) 16 (5.1)
TT ± CCD ? LND 164 5 (3.1) 1 (0.6) 6 (3.7)
MISC 69 0 (0.0) 1 (1.5) 1 (1.5)
REOP CCD UNIL/BIL 289 9 (3.1) 4 (1.4) 13 (4.5)
Total 1142 36 (3.2) 20 (1.8)a 56 (4.9)
HT ± CCD/LND hemithyroidectomy (with or without central or lateral compartment dissection), TT ±
CCD total thyroidectomy (with or without central compartment dissection), TT ± CCD ? LND total
thyroidectomy with lateral compartment dissection (with or without central compartment dissection), MISC
other (surgery not otherwise specified, mediastinoscopy, metastasectomy), REOP CCD UNIL/BIL reop-
eration in the central compartment, unilateral or bilateral. Bilateral surgeries are included for each side
aOne patient developed persistent recurrent nerve palsy after lateral neck dissection, following initial
surgery, in the central compartment
TABLE 5 Hypocalcemia
according to type of surgery and
number of patients
Type of surgery Total number of patients Hypocalcemia [n (%)]
Temporary (? unknown) Permanent Total
HT ± CCD/LND 306 9 (0.3) 2 (0.006) 11 (0.04)
TT ± CCD 157 32 (20.4) 11 (7.0) 43 (27.3)
TT ± CCD ? LND 82 30 (36.6) 14 (17.1) 44 (53.7)
MISC 88 3 (3.4) 0 (0.0) 3 (3.4)
REOP CCD UNIL/BIL 270 49 (18.2) 16 (5.9) 65 (24.1)
Total 903 124 (13.7)a 43 (4.8) 167 (18.5)
HT ± CCD/LND hemithyroidectomy (with or without central or lateral compartment dissection), TT ±
CCD total thyroidectomy (with or without central compartment dissection), TT ± CCD ? LND total
thyroidectomy with lateral compartment dissection (with or without central compartment dissection), MISC
other (surgery not otherwise specified, mediastinoscopy, metastasectomy), REOP CCD UNIL/BIL reop-
eration in the central compartment, unilateral or bilateral
aOne patient developed temporary hypocalcemia after reoperation in the lateral compartment following
extensive surgery, in the central and lateral compartment
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hemithyroidectomies were performed in all hospitals,
including low-volume hospitals. Higher percentages of
RLN palsy were seen in the teaching and peripheral hos-
pitals, although, due to small numbers, this was not
statistically different. An association between a lower risk
of RLN palsy in a high-volume center has been found by
others,23–26 and is also in accordance with a previous study
in which a better outcome was suggested in patients with
rare tumors when treated in a high-volume center.27
Temporary hypocalcemia was observed in about 14% of
DTC patients after thyroid surgery, and persistent
hypocalcemia was observed in almost 5%. These results
are comparable with earlier reports, with temporary
hypocalcemia reported at 8% and 38%, and persistent
hypocalcemia at 1% and 3%, respectively.12,28–30 Next to
initial total thyroidectomy, with or without concomitant
lateral compartment LN dissection, the highest percentage
of hypocalcemia was seen after reoperative surgery. As
described above, the type of thyroid surgery causing RLN
palsy was also at high risk of causing hypocalcemia. Our
data show that these procedures were performed in all
hospitals, including low-volume centers, during the period
of the study. However, note that our data only include
malignant thyroid surgery; benign surgery may have been
performed more frequently in hospitals with low-volume
thyroid cancer surgeries.
Our results also show that the majority of patients were
not referred to another (different level) hospital in case of
multiple operations. In addition, there was no difference in
referral patterns between patients with locally advanced
(T3-T4) tumors and small (T1-T2) tumors.
Early referral should especially be considered in patients
with locally advanced (T3–4) tumors, since these patients
frequently present with extrathyroidal spread and older age
([ 50 years), with a concomitant higher risk of incomplete
resection.31 In accordance with the literature, 75% of the
T3–4 tumors in our study were treated in high-volume
hospitals as they require more extensive surgical resection
or reoperations. However, we should be aware of the pre-
operative signs, as almost one-quarter of patients with T3
or T4 tumors (n = 48, 24.6%) still had their primary sur-
gical resection outside the university hospital. If in doubt
regarding extrathyroidal extension, proper preoperative
evaluation, including at least magnetic resonance imaging
and ultrasonography of the cervical region with laryngeal
examination, is recommended. These requirements are not
only needed to prevent reoperations but also for good
judgment in difficult cases during surgery, including
attempts to preserve the RLN, even in case of partial
encasement.
In 2007, the first national Dutch Thyroid Guidelines
were completed and gradually introduced into all hospitals
up to 2009 and thereafter.15 The data reported in this study,
including thyroid-specific, surgical-related complications,
should be seen as supporting data for the proposed work-
flow and hospital classification by level. These data can be
used as baseline data for comparing treatment outcomes
and QoL in future studies. Moreover these results will offer
us more insight into whether complication rates are
diminishing as a result of the current trend towards a less
aggressive treatment approach, with less extensive surgery
and even abstention of treatment in low-risk patients, as
suggested in the most recent American Thyroid Associa-
tion (ATA) guidelines.14,32–36
Due to the retrospective design of this study, there are a
number of limitations. We had to extract data on patient,
tumor, and treatment characteristics from patient records
and are therefore dependent on data recorded at that time.
Inclusion bias may have occurred, since more data were
available in the later years of the inclusion period, and
therefore more patients had to be excluded in the early
inclusion period (electronic supplementary Table 1).
Moreover, our exclusion group contained more follicular
thyroid carcinomas, more T1 stage tumors, and more M0
stage tumors, which could lead to bias since this group
might have more favorable characteristics than our inclu-
sion group. Pathology reports were standardized only in the
later inclusion years of this study, and therefore a number
of TNM stages are missing. Standardizing complication
registration occurred more frequently and earlier in the
university hospital, which could have led to a relative
underreporting of complications from the teaching and
peripheral hospitals. Moreover, preoperative laryngoscopy
was not routinely performed, which may have led to a
relative overreporting of RLN palsy, especially in patients
who only underwent a hemithyroidectomy.
CONCLUSIONS
The results of this population-based study, showing
highest RLN and hypocalcemia complication rates after
initial (hemi)thyroidectomy (with or without lateral com-
partment dissection) and after reoperations, support the
efforts in optimizing clinical management in thyroid can-
cer. Careful consideration should be made prior to initial
surgical treatment by way of early discussion in tele-
medicine-based regional tumor boards. This may lead to
better selection of low- and high-risk patients, with more
patient-oriented treatment of differentiated thyroid carci-
noma, as has been introduced in more recent years.
ACKNOWLEDGMENT The authors would like to thank Marion
Deken and Esther Klaver, all Data Managers at the Netherlands
Comprehensive Cancer Organization, and participating hospitals for
their essential help with the data retrieval.
Surgical Complications and Referrals in DTC 3879
DISCLOSURES Deborah van Dijk, Boukje A.C. van Dijk, Anne-
mieke Weistra, Thera P. Links, and John Th. M. Plukker have no
conflicts of interest to declare.
OPEN ACCESS This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons licence, and indicate
if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons licence, unless
indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons licence and your intended
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this licence, visit http://creativecommons.
org/licenses/by/4.0/.
REFERENCES
1. Table incidence thyroid cancer 1989–2019, Netherlands Cancer
Registry. Available at: https://www.cijfersoverkanker.nl/selectie
s/dataset_1/img5b34a7d166418. Accessed 28 Oct 2019.
2. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer
Inst. 2010;102(9):605–13.
3. Davies L, Welch HG. Increasing incidence of thyroid cancer in
the United States, 1973–2002. JAMA. 2006;295(18):2164–7.
4. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer ‘‘epi-
demic’’: screening and overdiagnosis. N Engl J Med.
2014;371(19):1765–7.
5. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery
affects survival for papillary thyroid cancer. Ann Surg.
2007;246(3):375–81 (discussion 381–4).
6. Kelly A, Barres B, Kwiatkowski F, et al. Age, thyroglobulin
levels and ATA risk stratification predict 10-year survival rate of
differentiated thyroid cancer patients. PLoS ONE.
2019;14(8):e0221298.
7. Cheah WK, Arici C, Ituarte PH, Siperstein AE, Duh QY, Clark
OH. Complications of neck dissection for thyroid cancer. World J
Surg. 2002;26(8):1013–6.
8. Chisholm EJ, Kulinskaya E, Tolley NS. Systematic review and
meta-analysis of the adverse effects of thyroidectomy combined
with central neck dissection as compared with thyroidectomy
alone. Laryngoscope. 2009;119(6):1135–9.
9. Giordano D, Valcavi R, Thompson GB, et al. Complications of
central neck dissection in patients with papillary thyroid carci-
noma: results of a study on 1087 patients and review of the
literature. Thyroid. 2012;22(9):911–7.
10. Glockzin G, Hornung M, Kienle K, et al. Completion thy-
roidectomy: effect of timing on clinical complications and
oncologic outcome in patients with differentiated thyroid cancer.
World J Surg. 2012;36(5):1168–73.
11. Pisanu A, Porceddu G, Podda M, Cois A, Uccheddu A. Sys-
tematic review with meta-analysis of studies comparing
intraoperative neuromonitoring of recurrent laryngeal nerves
versus visualization alone during thyroidectomy. J Surg Res.
2014;188(1):152–61.
12. Rosato L, Avenia N, Bernante P, et al. Complications of thyroid
surgery: analysis of a multicentric study on 14,934 patients
operated on in Italy over 5 years. World J Surg.
2004;28(3):271–6.
13. Husson O, Haak HR, Buffart LM, et al. Health-related quality of
life and disease specific symptoms in long-term thyroid cancer
survivors: a study from the population-based PROFILES registry.
Acta Oncol. 2013;52(2):249–58.
14. Haugen BR, Alexander EK, Bible KC, et al. 2015 American
Thyroid Association management guidelines for adult patients
with thyroid nodules and differentiated thyroid cancer: the
American Thyroid Association Guidelines Task Force on Thyroid
Nodules and Differentiated Thyroid Cancer. Thyroid.
2016;26(1):1–133.
15. Links TP, Huysmans DA, Smit JW, et al. Guideline ‘differenti-
ated thyroid carcinoma’, including diagnosis of thyroid nodules.
Ned Tijdschr Geneeskd. 2007;151(32):1777–82.
16. Gort M, Otter R, Plukker JT, Broekhuis M, Klazinga NS.
Actionable indicators for short and long term outcomes in rectal
cancer. Eur J Cancer. 2010;46(10):1808–14.
17. van der Sanden GA, Coebergh JW, Schouten LJ, Visser O, van
Leeuwen FE. Cancer incidence in The Netherlands in 1989 and
1990: first results of the nationwide Netherlands Cancer Registry.
Coordinating Committee for Regional Cancer Registries. Eur J
Cancer. 1995;31A(11):1822–9.
18. Bates MF, Lamas MR, Randle RW, et al. Back so soon? Is early
recurrence of papillary thyroid cancer really just persistent dis-
ease? Surgery. 2018;163(1):118–23.
19. van Dijk D, Plukker JT, van der Horst-Schrivers AN, et al. The
value of detectable thyroglobulin in patients with differentiated
thyroid cancer after initial 131I therapy. Clin Endocrinol (Oxf).
2011;74(1):104–10.
20. de Groot JW, Links TP, Rouwe CW, van der Wal JE, Hofstra
RM, Plukker JT. Prophylactic thyroidectomy in children who are
carriers of a multiple endocrine neoplasia type 2 mutation:
Description of 20 cases and recommendations based on the lit-
erature. Ned Tijdschr Geneeskd. 2006;150(6):311–8.
21. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB,
Pruet CW. Standardizing neck dissection terminology. Official
report of the academy’s committee for head and neck surgery and
oncology. Arch Otolaryngol Head Neck Surg.
1991;117(6):601–5.
22. Hayward NJ, Grodski S, Yeung M, Johnson WR, Serpell J.
Recurrent laryngeal nerve injury in thyroid surgery: a review.
ANZ J Surg. 2013;83(1–2):15–21.
23. Gourin CG, Tufano RP, Forastiere AA, Koch WM, Pawlik TM,
Bristow RE. Volume-based trends in thyroid surgery. Arch Oto-
laryngol Head Neck Surg. 2010;136(12):1191–8.
24. Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a
predictor of outcomes in inpatient and outpatient endocrine sur-
gery. Surgery. 2007;142(6):887–99 (discussion 887–99).
25. Adam MA, Thomas S, Youngwirth L, et al. Is there a minimum
number of thyroidectomies a surgeon should perform to optimize
patient outcomes? Ann Surg. 2017;265(2):402–7.
26. Lifante JC, Duclos A, Couray-Targe S, Colin C, Peix JL, Schott
AM. Hospital volume influences the choice of operation for
thyroid cancer. Br J Surg. 2009;96(11):1284–8.
27. Verhoef C, van de Weyer R, Schaapveld M, Bastiaannet E,
Plukker JT. Better survival in patients with esophageal cancer
after surgical treatment in university hospitals: a plea for per-
formance by surgical oncologists. Ann Surg Oncol.
2007;14(5):1678–87.
28. Verloop H, Louwerens M, Schoones JW, Kievit J, Smit JW,
Dekkers OM. Risk of hypothyroidism following hemithyroidec-
tomy: systematic review and meta-analysis of prognostic studies.
J Clin Endocrinol Metab. 2012;97(7):2243–55.
29. Su SY, Grodski S, Serpell JW. Hypothyroidism following
hemithyroidectomy: a retrospective review. Ann Surg.
2009;250(6):991–4.
30. Edafe O, Antakia R, Laskar N, Uttley L, Balasubramanian SP.
Systematic review and meta-analysis of predictors of post-thy-
roidectomy hypocalcaemia. Br J Surg. 2014;101(4):307–20.
31. Shindo ML, Caruana SM, Kandil E, et al. Management of inva-
sive well-differentiated thyroid cancer: an american head and
3880 D. van Dijk et al.
neck society consensus statement. AHNS consensus statement.
Head Neck. 2014;36(10):1379–90.
32. Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary
thyroid microcarcinoma: a study of 900 cases observed in a
60-year period. Surgery. 2008;144(6):980–7 (discussion 987–8).
33. Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of
the thyroid: a review of active surveillance trials. Eur J Surg
Oncol. 2018;44(3):307–15.
34. Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events
in the management of low-risk papillary microcarcinoma of the
thyroid by active surveillance versus immediate surgery. Thyroid.
2016;26(1):150–5.
35. Miyauchi A, Ito Y, Oda H. Insights into the management of
papillary microcarcinoma of the thyroid. Thyroid.
2018;28(1):23–31.
36. Links TP, de Heide LJ, Janssen M, et al. Guideline thyroid cancer
including diagnostics of the nodule. Ned Tijdschr Geneeskd.
2015;159:A9413.
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Surgical Complications and Referrals in DTC 3881
